SCHEMBL7420985

SCHEMBL7420985

CC(C)(CCNC(=O)c1ccc(NS(C)(=O)=O)cc1)CC(=O)N(Cc1ccccc1)C1(C#N)CCNC1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.43
KDM4E B2RXH2 2/20 0.43
SMN1; SMN2 Q16637 1/20 0.39
ADRB1 P08588 4/20 0.38
SIGMAR1 Q99720 2/20 0.38
TMEM97 Q5BJF2 1/20 0.38
EPHX2 P34913 1/20 0.37
NR1H4 Q96RI1 1/20 0.37
KMT2A Q03164 4/20 0.37
ADRB2 P07550 2/20 0.36
ADRB3 P13945 2/20 0.36
THRA P10827 2/20 0.36
THRB P10828 1/20 0.36
MEN1 O00255 3/20 0.35
VDR P11473 1/20 0.35
PKM P14618 1/20 0.35
OPRK1 P41145 1/20 0.34
NR3C2 P08235 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7419245 0.91 SIGMAR1 (0.41) ALDH1A1SIGMAR1TMEM97
SCHEMBL7420982 0.80 CTSL (0.36) ALDH1A1KDM4EADRB1EPHX2NR1H4
SCHEMBL7014342 0.79 CTSS (0.41) ALDH1A1KDM4ESMN1; SMN2ADRB1EPHX2
SCHEMBL7420196 0.77 CTSS (0.36) KMT2AMEN1
SCHEMBL7014338 0.75 CTSS (0.44) ALDH1A1ADRB1KMT2A
SCHEMBL7420191 0.67 SNCA (0.34)
SCHEMBL10645072 0.67 SIGMAR1 (0.68) ALDH1A1KDM4ESIGMAR1TMEM97OPRK1
SCHEMBL7419141 0.65 AGER (0.39) SIGMAR1TMEM97
SCHEMBL10643150 0.65 OPRK1 (0.66) ALDH1A1KDM4ESMN1; SMN2THRBOPRK1
SCHEMBL7413191 0.64 CTSS (0.37) ALDH1A1KDM4ESIGMAR1TMEM97EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1218372-A1 NOVEL SPIROHETEROCYCLIC COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES Boehringer Ingelheim Pharmaceuticals, Inc. (US) 2002-07-03 EP disclosed
WO-2001019816-A1 NOVEL SPIROHETEROCYCLIC COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2001-03-22 WO disclosed